|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
The following personnel announcements at New England-area biotech companies have been made in recent weeks: Cambridge, Mass... Read More
from Business Journals
Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting
May 24, 2013
Battle lines are being drawn two weeks before a highly unusual two-day FDA advisory committee meeting to discuss the contentious diabetes drug rosiglitazone (Avandia, GlaxoSmithKline). This will be the... Read More
category
NYSE:GSK
from Forbes Real Time
|